Dicerna Pharmaceuticals
DRNA
#3999
Rank
โ‚ฌ2.56 B
Marketcap
32,95ย โ‚ฌ
Share price
0.00%
Change (1 day)
15,601.65%
Change (1 year)

Market capitalization of Dicerna Pharmaceuticals (DRNA)

Last known market cap: โ‚ฌ2.56 Billion

As of March 2026 Dicerna Pharmaceuticals has a market cap of โ‚ฌ2.56 Billion. This makes Dicerna Pharmaceuticals the world's 3999th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Dicerna Pharmaceuticals from 2014 to 2022

End of year Market Cap

Year Marketcap Change
2022โ‚ฌ2.77 B5.58%
2021โ‚ฌ2.62 B93.78%
2020โ‚ฌ1.35 B-3.6%
2019โ‚ฌ1.40 B120.83%
2018โ‚ฌ0.63 B64%
2017โ‚ฌ0.38 B583.98%
2016โ‚ฌ56.82 M-74.58%
2015โ‚ฌ0.22 B-7.18%
2014โ‚ฌ0.24 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
โ‚ฌ130.27 B 4,975.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ175.18 B 6,725.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ255.38 B 9,849.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
โ‚ฌ0.48 B-81.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚ฌ36.42 B 1,319.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
โ‚ฌ7.73 B 201.44%๐Ÿ‡บ๐Ÿ‡ธ USA